Tirzepatide , the active ingredient in both Mounjaro and Zepbound is currently being evaluated in phase 3 trials for cardiovascular outcomes in diabetes patients, heart failure with preserved ejection fraction, morbidity and mortality in obesity, and obstructive sleep apnea (OSA)
On paper, Inno Shred GLP-1 looks like a budget-friendly way to mimic prescription GLP-1s
10.1111/j.1528-1167.2008.01832.x 54
Specifically, we adopted disproportionality analysis to identify AEs highly associated with GLP-1 RA post-treatment
The current variant is relatively moderate, and if they are otherwise healthy, they can weather the storm. The medication comes with a long list of other drugs that may not be taken at the same time, and it can also produce some unpleasant side effects, such as diarrhea, so Salter and other physicians say they weigh the benefits and risks with patients
A smarter approach: reconstitute only 2 mg worth at a time by adding 0.8 mL of water to a portion of the powder